Guazzelli, Alice <br/><br/>
Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.  [electronic resource] 

 -  Expert opinion on investigational drugs  Aug 2017 
 - 933-944 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7658 
<br/><br/><label>Standard No.: </label>10.1080/13543784.2017.1351545  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Drug Design<br/>Drugs, Investigational--pharmacology<br/>Humans<br/>Immunotherapy--methods<br/>Mesothelioma--drug therapy<br/>Molecular Targeted Therapy<br/>Peritoneal Neoplasms--drug therapy<br/>Pleural Neoplasms--drug therapy<br/>Quality of Life<br/>Survival Rate